Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
about
Characterization of Scedosporium apiospermum glucosylceramides and their involvement in fungal development and macrophage functionsA Multifaceted Study of Scedosporium boydii Cell Wall Changes during Germination and Identification of GPI-Anchored ProteinsRapid development of a mycotic aneurysm of the intracranial artery secondary to Scedosporium apiospermum sinusitisEnvironmental Screening for the Scedosporium apiospermum Species Complex in Public Parks in Bangkok, ThailandImpact of multidrug-resistant organisms on patients considered for lung transplantation.In vitro antifungal activity of isavuconazole against Madurella mycetomatisIsavuconazole: A New Option for the Management of Invasive Fungal Infections.Name changes in medically important fungi and their implications for clinical practice.Susceptibility and diversity in the therapy-refractory genus scedosporiumPhenotypic profiling of Scedosporium aurantiacum, an opportunistic pathogen colonizing human lungs.Identification of filamentous fungi isolates by MALDI-TOF mass spectrometry: clinical evaluation of an extended reference spectra library.Specific antifungal susceptibility profiles of opportunists in the Fusarium fujikuroi complex.Etest cannot be recommended for in vitro susceptibility testing of mucorales.Performance of Matrix-Assisted Laser Desorption Ionization-Time of Flight Mass Spectrometry for Identification of Aspergillus, Scedosporium, and Fusarium spp. in the Australian Clinical Setting.Fungal epidemiology and diversity in cystic fibrosis patients over a 5-year period in a national reference center.Comparing Etest and Broth Microdilution for Antifungal Susceptibility Testing of the Most-Relevant Pathogenic Molds.In Vitro Activity of Isavuconazole against Rasamsonia SpeciesTenosynovitis caused by Scedosporium apiospermum infection misdiagnosed as an Alternaria species: a case report.Molecular and cellular responses of the pathogenic fungus Lomentospora prolificans to the antifungal drug voriconazole.Challenges in Laboratory Detection of Fungal Pathogens in the Airways of Cystic Fibrosis Patients.Emerging fungal infections in solid organ transplant recipients.Safety and clinical response of intraventricular caspofungin for Scedosporium apiospermum complex central nervous system infection.Proteomics of hosts and pathogens in cystic fibrosis.Isavuconazole, a broad-spectrum triazole for the treatment of systemic fungal diseases.Unpredictable susceptibility of emerging clinical moulds to tri-azoles: review of the literature and upcoming challenges for mould identification.Scedosporium apiospermum Otitis Complicated by a Temporomandibular Arthritis: A Case Report and Mini-Review.Scedosporium apiospermum infections and the role of combination antifungal therapy and GM-CSF: A case report and review of the literature.Isavuconazonium sulfate: a triazole prodrug for invasive fungal infections.Use of Fungal Diagnostics and Therapy in Pediatric Cancer Patients in Resource-Limited Settings.Isavuconazole: a new extended spectrum triazole for invasive mold diseases.Conidial germination in Scedosporium apiospermum, S. aurantiacum, S. minutisporum and Lomentospora prolificans: influence of growth conditions and antifungal susceptibility profiles.A Case of Cutaneous Mycosis Caused by Scedosporium dehoogii on an Immunocompromised Patient.Effects of Photodynamic Therapy on the Growth and Antifungal Susceptibility of Scedosporium and Lomentospora spp.Progress in Definition, Prevention and Treatment of Fungal Infections in Cystic Fibrosis.Scedosporium apiospermum complex in cystic fibrosis; should we treat?Comparative Pathogenicity of Lomentospora prolificans (Scedosporium prolificans) Isolates from Mexican Patients.Voriconazole MICs are predictive for the outcome of experimental disseminated scedosporiosis.Clinical and morphologic findings in disseminated Scedosporium apiospermum infections in immunocompromised patients.Combination Antifungal Therapy in the Treatment of Scedosporium apiospermum Central Nervous System Infections.Semi-automated repetitive sequence-based PCR amplification for species of the Scedosporium apiospermum complex.
P2860
Q28539197-43595DEF-FEE9-4643-9505-B1BCD71E6C4BQ28547775-C5EF4A13-8614-49E3-840E-84C51808599CQ28818414-9BFB3D20-554C-4507-BC13-A33746FAB927Q28828486-B10D77FA-B3D9-4D91-A821-29586257A494Q33576059-22AE006C-A577-487A-A6B6-B0528931789DQ34298778-47ED9D11-06AE-417E-A125-4FA1C6A94596Q34474946-FB16FAE6-52E3-4BA4-8232-371099B00184Q35193147-F00A1E08-67F3-435F-A7FC-EBDE15F95203Q35214490-0EB7414D-EDB8-40F3-8A5B-6555821B3E16Q35220005-EB55CD2C-5A40-4817-BB2A-ABEFE0F1A323Q35370259-7B009CF2-004D-4B93-A60E-8B5D217BC003Q35533576-DF646044-FDA1-483B-8738-878D4AB0820DQ35595623-DC52CC6D-8B93-4DBC-948C-032994A5A12DQ36037566-2EC8368B-8790-4D29-988D-5A99540798CFQ36065422-676B1BF1-558C-4355-B684-68B6164B8BF8Q36066784-51A41A92-D488-4A46-87C4-4C4915446850Q36104417-649A0F9F-8DE3-47C9-AFA0-0DA9AB24A404Q36249753-D82139E8-7554-491E-8302-09DD719AE75AQ36330214-2939A034-B238-46C7-BB69-A04DFB518CA0Q36394592-162FC770-9A5E-4E58-9A91-EB9C043188F2Q36949523-76EFD625-9EE1-4772-ADED-8CDD52CEFBE4Q37253708-A6DA23A5-F5BD-4D85-B4F7-E68641BB3AF9Q38270707-F37A4038-465B-4653-8935-2FF16037DEE7Q38285488-B1AED6F3-4513-4378-95EC-3BC5B7E7B1B0Q38430959-3331FD1F-CF8C-419A-BF52-57ADF2B82F67Q38536383-C652C04F-E0FB-47E5-B4DC-61C90E02F2C8Q38835132-14A33D84-2DEB-4DD2-AB20-1A3E90F4AE6EQ38939506-2C2762BF-7503-413B-AA98-DD74260B6B79Q38965488-03DFA14F-82AA-4E57-AEDB-A26B99F05300Q39003715-7B0AC8C1-F2DA-4C72-9A73-E589671D70B0Q39646345-EB7A09AE-8CC0-4F54-A57D-71AD1052D294Q40069982-2CF0ED31-D3D9-4BFB-B56B-B52F2BD533B8Q40081715-D140A451-FA28-4CFF-A449-9C8FC7B43DA5Q40111798-8000EAA2-4F7F-4058-BD4F-CA5AEAD8C7C8Q40212908-84E044DB-52ED-4904-A8B0-16E38E01825FQ40232499-F76A0680-70B3-4E01-87AA-F8DF03153441Q40392406-4E86E6BE-E831-487D-A9BE-3665184DC2F3Q40768828-6C67B071-0D3E-476D-830D-E4FC18F82F01Q40811183-3E5CA2E5-43D1-4B13-BC84-CB36FC2529BBQ40943164-B514C16B-A02C-418D-91B3-E6EAF22FD0FD
P2860
Species-specific antifungal susceptibility patterns of Scedosporium and Pseudallescheria species.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Species-specific antifungal su ...... and Pseudallescheria species.
@en
Species-specific antifungal su ...... and Pseudallescheria species.
@nl
type
label
Species-specific antifungal su ...... and Pseudallescheria species.
@en
Species-specific antifungal su ...... and Pseudallescheria species.
@nl
prefLabel
Species-specific antifungal su ...... and Pseudallescheria species.
@en
Species-specific antifungal su ...... and Pseudallescheria species.
@nl
P2093
P2860
P50
P356
P1476
Species-specific antifungal su ...... m and Pseudallescheria species
@en
P2093
Corné H Klaassen
G Sybren de Hoog
Ilse Curfs-Breuker
P2860
P304
P356
10.1128/AAC.05910-11
P407
P577
2012-01-30T00:00:00Z